Cargando…

Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia

in silico modeling, using Psipred and ExPASy servers was employed to determine the structural elements of Bcr-Abl oncoprotein (p210(BCR-ABL)) isoforms, b2a2 and b3a2, expressed in Chronic Myelogenous Leukemia (CML). Both these proteins are tyrosine kinases having masses of 210-kDa and differing only...

Descripción completa

Detalles Bibliográficos
Autores principales: Hai, Abdul, Kizilbash, Nadeem A, Zaidi, Syeda Huma H, Alruwaili, Jamal, Shahzad, Khuram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974235/
https://www.ncbi.nlm.nih.gov/pubmed/24748748
http://dx.doi.org/10.6026/97320630010108
Descripción
Sumario:in silico modeling, using Psipred and ExPASy servers was employed to determine the structural elements of Bcr-Abl oncoprotein (p210(BCR-ABL)) isoforms, b2a2 and b3a2, expressed in Chronic Myelogenous Leukemia (CML). Both these proteins are tyrosine kinases having masses of 210-kDa and differing only by 25 amino acids coded by the b3 exonand an amino acidsubstitution (Glu903Asp). The secondary structure elements of the two proteins show differences in five α-helices and nine β-strands which relates to differences in the SH(3), SH(2), SH1 and DNA-binding domains. These differences can result in different roles played by the two isoforms in mediating signal transduction during the course of CML.